Allurion Technologies Investor Relations Material

Allurion Technologies Inc. is a healthcare company operating in the medical devices industry, primarily focused on combating obesity. The company's flagship offering is the Allurion Program, a comprehensive weight loss platform that includes the Allurion Balloon, a novel, swallowable, and procedure-less intragastric balloon designed to facilitate weight loss. Beyond the balloon, Allurion provides an integrated suite of digital health tools for both patients and healthcare providers, including the Allurion Virtual Care Suite, which features AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth services. These offerings aim to customize, monitor, and manage weight loss therapy for patients, irrespective of their specific treatment plan. Allurion Technologies Inc. is headquartered in Natick, Massachusetts, and its shares are listed on the New York Stock Exchange.